Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FHY9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,508
Award facts
- Contract value 100% obligated
- $12,508.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,508.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). This firm fixed-price delivery order, issued on November 5, 2025, with completion targeted for November 6, 2025, represents a direct fulfillment of pharmaceutical needs through the federal supply chain. The award was made without a set-aside designation, indicating competitive selection among qualified vendors. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is well-established as a critical vendor for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Zepbound, a weight management medication, aligns with the contract's scope of specialty pharmaceuticals and brand-name drugs. The delivery order fulfills immediate pharmaceutical requirements for Defense Health Agency customers and other federal healthcare systems supported through DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FHY9E?
SPE2DR26FHY9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FHY9E worth?
The government has obligated $12,508 on SPE2DR26FHY9E.
Is contract SPE2DR26FHY9E an order under another contract?
Yes. SPE2DR26FHY9E is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY9E competed?
The extent of competition for SPE2DR26FHY9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award